The clinical evidences of the guideline came from clinical trials based evidence-based medicine. Applied principle of the evidence was: systematic reviews, RCTs, the results from multiple factors analysis, consensus, especially combined with Chinese experience and some lung cancer guidelines used in USA or Europe. All doctors who use the guideline in making therapeutic strategy must combine patients' conditions with the knowledge of biological behavior, dynamic change and response to treatment of lung cancer.
|Number of pages||5|
|Journal||Chinese Journal of Lung Cancer|
|State||Published - Oct 2004|
- Evidence-based medicine
- Lung neoplasms/surgery